ClinicalTrials.govpublic full text
A Study to Evaluate the Effect of Long-term Treatment With BELVIQ (Lorcaserin HCl) on the Incidence of Major Adverse Cardiovascular Events and Conversion to Type 2 Diabetes Mellitus in Obese and Overweight Subjects With Cardiovascular Disease or Multiple Cardiovascular Risk Factors
cardiovascular disease, high cardiovascular risk, obesity, overweight, type 2 diabetes
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 201724
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.